Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Health Protection Research Initiative Investigator Initiated Research, Program Announcement CD 04 002

---
identifier: "/us/fr/05-8882"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Health Protection Research Initiative Investigator Initiated Research, Program Announcement CD 04 002"
title_number: 0
title_name: "Federal Register"
section_number: "05-8882"
section_name: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Health Protection Research Initiative Investigator Initiated Research, Program Announcement CD 04 002"
positive_law: false
currency: "2005-05-04"
last_updated: "2005-05-04"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "05-8882"
document_type: "notice"
publication_date: "2005-05-04"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "70 FR 23174"
fr_volume: 70
---


#  Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Health Protection Research Initiative Investigator Initiated Research, Program Announcement CD 04 002

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following meeting:

*Name:* Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Health Protection Research Initiative Investigator Initiated Research, Program Announcement CD 04 002.

*Times and Dates:* 11 a.m.-12:30 p.m., June 6, 2005 (Closed).

*Place:* Centers for Disease Control and Prevention/Office of Public Health Research, 1 West Court Square, Suite 7000, Room 7009, Mailstop D-72, Decatur, GA 30030, Telephone 404-371-5253.

*Status:* The meeting will be closed to the public in accordance with provisions set forth in section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.

*Matters To Be Discussed:* The meeting will include the review, discussion, and evaluation of applications received in response to Health Protection Research Initiative Investigator Initiated Research, Program Announcement CD 04 002.

*Contact Person for More Information:* Mary L. Lerchen, DrPH, MS, Designated Federal Official, Office of Chief of Science, CDC, Office of Public Health Research, 1 West Court Square, Suite 7000, Room 709, Mailstop D-72, Decatur, GA 30030, Telephone 404-371-5282.

The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.

Dated: April 27, 2005.

Alvin Hall,

Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.